With the increasing health awareness among the masses, an immensurable technological upheaval has been recorded in the medical industry. Blending medical technology with human touch, Medical/Healthcare industry keeps healthy everyone from newborn to the critically ill. With this expansion in Medical/Healthcare sector, the need of the professionals is also gaining strength day by day. Intelligence, passion for humanity and genuine compassion of the medical professionals make them the preferred choice in various healthcare centers.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Baxter India is a wholly owned subsidiary of Baxter International Inc. (NYSE:BAX). Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non – government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
If you are on dialysis like approximately 400,000 other Americans, then your life could change for the better in the next couple of years thanks to some new biomedical engineering.
The technology, announced this week at an American Heart Association conference on emerging technology, enables engineers to grow sheets of human cells in a laboratory, and then synthesize them into tubes, mimicking human blood vessels. Alternatively, the human cells, which come from skin cells, can be made into threads and then woven into the form of blood vessels.
